Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Evaluation of self-reported medication adherence and its associated factors among epilepsy patients in Hospital Kuala Lumpur.

Molugulu N, Gubbiyappa KS, Vasudeva Murthy CR, Lumae L, Mruthyunjaya AT.

J Basic Clin Pharm. 2016 Sep;7(4):105-109. doi: 10.4103/0976-0105.189430.

2.

Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis.

Medic G, Higashi K, Littlewood KJ, Diez T, Granström O, Kahn RS.

Neuropsychiatr Dis Treat. 2013;9:119-31. doi: 10.2147/NDT.S39303.

3.

Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets.

Phaechamud T, Mueannoom W, Tuntarawongsa S, Chitrattha S.

Indian J Pharm Sci. 2010 Mar;72(2):173-83. doi: 10.4103/0250-474X.65026.

4.

Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations.

Bhosle M, Benner JS, Dekoven M, Shelton J.

Patient Prefer Adherence. 2009 Nov 3;3:161-71.

5.

Extended-release formulations of antiepileptic drugs: rationale and comparative value.

Perucca E.

Epilepsy Curr. 2009 Nov-Dec;9(6):153-7. doi: 10.1111/j.1535-7511.2009.01326.x.

6.

Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations.

Fujii A, Yasui-Furukori N, Nakagami T, Niioka T, Saito M, Sato Y, Kaneko S.

Drug Des Devel Ther. 2009 Feb 6;2:139-44.

7.

Managing patient adherence and quality of life in epilepsy.

Eatock J, Baker GA.

Neuropsychiatr Dis Treat. 2007 Feb;3(1):117-31.

8.

WebEase: development of a Web-based epilepsy self-management intervention.

DiIorio C, Escoffery C, Yeager KA, McCarty F, Henry TR, Koganti A, Reisinger E, Robinson E, Kobau R, Price P.

Prev Chronic Dis. 2009 Jan;6(1):A28.

Items per page

Supplemental Content

Support Center